ARCHIVES

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

This article is from The Cancer Letter archive.

Vol. 01 No. 10 | April 12, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

October 21, 1988

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

Feinstein Reintroduces New National Cancer Act

June 13, 2003

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984